Apuzzo, M., Gebrekidan, S. (2021). Governments sign secret vaccine deals. Here’s what they hide. The New York Times. Retrieved December 31, 2025, from https://www.nytimes.com/2021/01/28/world/europe/vaccine-secret-contracts-prices.html?searchResultPosition=

Arevadze, N. (2019). The role of the concept of trade secrets in the imbalance of collective labor relations. Retrieved January 30, 2026, from https://socialjustice.org.ge/ka/products/komertsiulisaidumloebiskontseftissakanonmdeblomimokhilvadamisipraktikuligamoqenebashromitdavashiadgilobrividasaertashorisopolitikismimokhilva

Barfield, C., Calfee, J. E. (2007). Biotechnology and the patent system: Balancing innovation and property rights. Washington: The AEI Press.

Basic Concept of Vaccination. (n.d.). Retrieved January 11, 2026, from http://www.phrma-jp.org/wordpress/wp-content/uploads/old/library/vaccine-factbook_e/1_Basic_Concept_of_Vaccination.pdf

Boschiero, N. (2022). COVID-19 vaccines as global common goods: An integrated approach of ethical, economic policy and intellectual property management. Berlin–Boston: Walter de Gruyter GmbH.

Coronavirus (COVID-19) Vaccinations – statistics by country and year. Retrieved October 20, 2025, from https://ourworldindata.org/covid-vaccinations

Cullet, P., Yuanquiong, H. (2018). Medical Patents and the Right to Health – From Monopoly Control to Open Access Innovation and Provision of Medicine. German Yearbook of International Law, 61(1), pp. 153–182. https://doi.org/10.3790/gyil.61.1.153

De Abrantes, N. (2016). Vaccines – Patent eligible now or no: An assessment of the patent eligibility of an Ebola vaccine in light of recent Supreme Court decisions. AIPLA Quarterly Journal, 44(3), pp. 528–534.

Dickhut, S. M. (2017). Ethical and procedural barriers to accessing critical medicines in least developed countries: A look at TRIPS and the Doha documents. Journal of Gender, Race & Justice, 20(1), pp. 219–231.

Durkin, A., Sta, M., Willmore, B., Kapczynski, A. (2021). Addressing the risks that trade secret protections pose for health and rights. Health and Human Rights Journal, 23(1), pp. 130–163.

Dzamukashvili D. (2002). ინტელექტუალური საკუთრების სამართალი, საერთაშორისო შეთანხმებები და ხელშეკრულებები. თბილისი (Intellectual Property Law, International Agreements and Conventions). Tbilisi: SANI.

Feldman, R., Graves, C. (2020). Naked price and pharmaceutical trade secret overreach. Yale Journal of Law & Technology, 22, pp. 106–114.

Gregersen, J. P. (1994). Research and development of vaccines and pharmaceuticals from bio-technology: A guide to effective project management, patenting and product registration. Weinheim–New York–Basel–Cambridge–Tokyo: VCH.

History of Vaccines. (n.d.). What do vaccines do? Different types of vaccines. Retrieved January 11, 2026, from https://historyofvaccines.org/vaccines-101/what-do-vaccines-do/different-types-vaccines

Kaplan, Y., Marcowitz-Bitton, M. (2022). Recalibrating patent protection for COVID-19 vaccines: A path to affordable access and equitable distribution. UC Irvine Law Review, 12(2), pp. 430–450.

Kaplow, L., Shavell, S. (1995–1996). Property Rules versus Liability Rules: An Economic Analysis. Harvard Law Review, 109(4), pp. 754–757. https://doi.org/10.2307/1342135

Lester, S., Huan, Z. H. (2019). Rethinking the length of patent terms. American University International Law Review, 34(4), pp. 787–790.

Lupkin, S. (2020). COVID-19 Vaccine Contract Accountability. HHS Released More Coronavirus Vaccine Contracts As Election Results Unfolded. Retrieved November 10, 2025, from https://www.npr.org/sections/health-shots/2020/11/08/932793698/hhs-released-more-coronavirus-vaccine-contracts-as-election-results-unfolded

Menell, P. S. (2017). Tailoring a Public Policy Exception to Trade Secret Protection. California Law Review, 105(1), pp. 1–63.

Mitnovetski, O., Nicol, D. (2004). Are patents of medical treatment contrary to the ordre public and morality or “generally inconvenient”? Journal of Medical Ethics, 30(5), pp. 470–476. https://doi.org/10.1136/jme.2002.000786

Morten, C. J., Kapczynski, A. (2021). The Big Data Regulator, Rebooted: Why and How the FDA Can and Should Disclose Confidential Data on Prescription Drugs and Vaccines. The Yale Journal of Law & Technology, 22, pp. 180–190. https://doi.org/10.15779/Z380K26C1T

Naik, S. (2021). Intellectual Property Waiver on Covid Vaccines. International Journal of Law Management & Humanities, 4(3), pp. 4516–4519.

NPR. (2020, November 8). HHS released more coronavirus vaccine contracts as election results unfolded. Retrieved November 10, 2025, from https://www.npr.org/sections/health-shots/2020/11/08/932793698/hhs-released-more-coronavirus-vaccine-contracts-as-election-results-unfolded

Our World in Data. (n.d.). See statistics by country and year. Retrieved October 20, 2025, from https://ourworldindata.org/covid-vaccinations

Sakpatenti. (n.d.). Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). Retrieved October 20, 2025, from https://www.sakpatenti.gov.ge/media/page_files/trips_1.pdf

Santos, R. A. (2018). Vaccine Licensure in the Public Interest: Lessons from the Development of the U.S. Army Zika Vaccine. The Yale Law Journal Forum, 127, pp. 652–665.

Santos, R. A. (2021). Property and Intellectual Property in Vaccine Markets. Texas A&M Journal of Property Law, 7(1), pp. 110–136.

Tikaradze, T. (2015). ინტელექტუალურ საკუთრების დაცვის პოზიტიური და ნეგატიური ასპექტები (Positive and negative aspects of intellectual property rights protection). Academic Herald, 117.

Togoh, I. (2020). Health Secretary Alex Azar refuses to guarantee coronavirus vaccine would be affordable for all. Forbes. Retrieved October 20, 2025, from https://www.forbes.com/sites/isabeltogoh/2020/02/27/health-secretary-alex-azar-refuses-to-guarantee-coronavirus-vaccine-would-be-affordable-for-all/?sh=1c3c17c6490c

World Trade Organization (n.d.). Amendment of the TRIPS Agreement. Retrieved October 27, 2025, from https://www.wto.org/english/tratop_e/trips_e/amendment_e.htm